Compare HRMY & VVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRMY | VVX |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2020 | 2014 |
| Metric | HRMY | VVX |
|---|---|---|
| Price | $39.00 | $55.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | $51.33 | ★ $62.60 |
| AVG Volume (30 Days) | ★ 789.9K | 294.5K |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.44 | ★ 791.53 |
| EPS | ★ 3.17 | 2.51 |
| Revenue | $825,944,000.00 | ★ $4,419,142,000.00 |
| Revenue This Year | $23.11 | $4.42 |
| Revenue Next Year | $16.15 | $5.45 |
| P/E Ratio | ★ $12.79 | $21.81 |
| Revenue Growth | ★ 21.13 | 5.10 |
| 52 Week Low | $25.52 | $41.08 |
| 52 Week High | $40.93 | $63.74 |
| Indicator | HRMY | VVX |
|---|---|---|
| Relative Strength Index (RSI) | 67.08 | 49.36 |
| Support Level | $38.12 | $53.81 |
| Resistance Level | $40.00 | $58.32 |
| Average True Range (ATR) | 1.26 | 1.73 |
| MACD | 0.13 | 0.15 |
| Stochastic Oscillator | 68.68 | 47.65 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.